Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

Medications that have transformed the treatment of obesity may also help people drink less alcohol, according to new government-funded research.

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

In a world where alcohol claims nearly 178,000 lives annually in the U.S. alone, a glimmer of hope has emerged from an ...

Semaglutide, the drug sold as Ozempic to treat type 2 diabetes and Wegovy for weight loss, reduced alcohol cravings and ...

A small study confirms observations what users have observed: the medications reduce their cravings for alcohol.

Covering some 1.9million people in the UK, private health insurer Vitality has become the country’s first provider to offer ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

If the CMS rule to cover obesity medications is finalized, coverage will increase by other insurers, experts predicted. HHS ...

The new findings add to growing evidence that the medicines could help people with alcohol addiction. View on euronews ...